Loading…

A response to the opioid overdose epidemic: naloxone nasal spray

Opioid overdose morbidity and mortality is recognized to have epidemic proportions. Medical and public health agencies are adopting opioid harm reduction strategies to reduce the morbidity and mortality associated with overdose. One strategy developed by emergency medical services and public health...

Full description

Saved in:
Bibliographic Details
Published in:Drug delivery and translational research 2013-02, Vol.3 (1), p.63-74
Main Author: Wermeling, Daniel P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3
cites cdi_FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3
container_end_page 74
container_issue 1
container_start_page 63
container_title Drug delivery and translational research
container_volume 3
creator Wermeling, Daniel P.
description Opioid overdose morbidity and mortality is recognized to have epidemic proportions. Medical and public health agencies are adopting opioid harm reduction strategies to reduce the morbidity and mortality associated with overdose. One strategy developed by emergency medical services and public health agencies is to deliver the opioid antidote naloxone injection intranasally to reverse the effects of opioids. Paramedics have used this route to quickly administer naloxone in a needle-free system and avoiding needlestick injuries and contracting a blood-born pathogen disease such as hepatitis or human immunodeficiency virus. Public health officials advocate broader lay person access since civilians are likely witnesses or first responders to an opioid overdose in a time-acute setting. The barrier to greater use of naloxone is that a suitable and optimized needle-free drug delivery system is unavailable. The scientific basis for design and study of an intranasal naloxone product is described. Lessons from nasal delivery of opioid analgesics are applied to the consideration of naloxone nasal spray.
doi_str_mv 10.1007/s13346-012-0092-0
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3668569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1665117285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoKuoP8CI9eqnmO40HURa_QPCi4C2kzXQ30m1q0l3cf29kddGLc8gMmXfeZB6Ejgk-Ixir80QY47LEhJYY63xsoX1KNC6Z5tX2pmave-gopTecg0uitNpFe5Qpxhmn--jquoiQhtAnKMZQjDMowuCDd0VYQnQhX8PgHcx9c1H0tgsfoYdcJNsVaYh2dYh2WtslOPrOB-jl9uZ5cl8-Pt09TK4fy4ZzOpaCVHWlWwlCcSaorEgl6tbh1um61qRWNTQUNLPONUKrvJAiYB0lXFgmpGUH6HLtOyzqObgG-jHazgzRz21cmWC9-dvp_cxMw9IwKSshdTY4_TaI4X0BaTRznxroOttDWCRDpBSEKFqJLCVraRNDShHazTMEmy_4Zg3fZPjmC77Beebk9_82Ez-os4CuBRmb76cQzVtYxIw0_eP6Cdfjj9Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1665117285</pqid></control><display><type>article</type><title>A response to the opioid overdose epidemic: naloxone nasal spray</title><source>Springer Nature</source><creator>Wermeling, Daniel P.</creator><creatorcontrib>Wermeling, Daniel P.</creatorcontrib><description>Opioid overdose morbidity and mortality is recognized to have epidemic proportions. Medical and public health agencies are adopting opioid harm reduction strategies to reduce the morbidity and mortality associated with overdose. One strategy developed by emergency medical services and public health agencies is to deliver the opioid antidote naloxone injection intranasally to reverse the effects of opioids. Paramedics have used this route to quickly administer naloxone in a needle-free system and avoiding needlestick injuries and contracting a blood-born pathogen disease such as hepatitis or human immunodeficiency virus. Public health officials advocate broader lay person access since civilians are likely witnesses or first responders to an opioid overdose in a time-acute setting. The barrier to greater use of naloxone is that a suitable and optimized needle-free drug delivery system is unavailable. The scientific basis for design and study of an intranasal naloxone product is described. Lessons from nasal delivery of opioid analgesics are applied to the consideration of naloxone nasal spray.</description><identifier>ISSN: 2190-393X</identifier><identifier>EISSN: 2190-3948</identifier><identifier>DOI: 10.1007/s13346-012-0092-0</identifier><identifier>PMID: 23734342</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Pharmaceutical Sciences/Technology ; Review Article</subject><ispartof>Drug delivery and translational research, 2013-02, Vol.3 (1), p.63-74</ispartof><rights>Controlled Release Society 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3</citedby><cites>FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23734342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wermeling, Daniel P.</creatorcontrib><title>A response to the opioid overdose epidemic: naloxone nasal spray</title><title>Drug delivery and translational research</title><addtitle>Drug Deliv. and Transl. Res</addtitle><addtitle>Drug Deliv Transl Res</addtitle><description>Opioid overdose morbidity and mortality is recognized to have epidemic proportions. Medical and public health agencies are adopting opioid harm reduction strategies to reduce the morbidity and mortality associated with overdose. One strategy developed by emergency medical services and public health agencies is to deliver the opioid antidote naloxone injection intranasally to reverse the effects of opioids. Paramedics have used this route to quickly administer naloxone in a needle-free system and avoiding needlestick injuries and contracting a blood-born pathogen disease such as hepatitis or human immunodeficiency virus. Public health officials advocate broader lay person access since civilians are likely witnesses or first responders to an opioid overdose in a time-acute setting. The barrier to greater use of naloxone is that a suitable and optimized needle-free drug delivery system is unavailable. The scientific basis for design and study of an intranasal naloxone product is described. Lessons from nasal delivery of opioid analgesics are applied to the consideration of naloxone nasal spray.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Review Article</subject><issn>2190-393X</issn><issn>2190-3948</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMoKuoP8CI9eqnmO40HURa_QPCi4C2kzXQ30m1q0l3cf29kddGLc8gMmXfeZB6Ejgk-Ixir80QY47LEhJYY63xsoX1KNC6Z5tX2pmave-gopTecg0uitNpFe5Qpxhmn--jquoiQhtAnKMZQjDMowuCDd0VYQnQhX8PgHcx9c1H0tgsfoYdcJNsVaYh2dYh2WtslOPrOB-jl9uZ5cl8-Pt09TK4fy4ZzOpaCVHWlWwlCcSaorEgl6tbh1um61qRWNTQUNLPONUKrvJAiYB0lXFgmpGUH6HLtOyzqObgG-jHazgzRz21cmWC9-dvp_cxMw9IwKSshdTY4_TaI4X0BaTRznxroOttDWCRDpBSEKFqJLCVraRNDShHazTMEmy_4Zg3fZPjmC77Beebk9_82Ez-os4CuBRmb76cQzVtYxIw0_eP6Cdfjj9Q</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Wermeling, Daniel P.</creator><general>Springer US</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130201</creationdate><title>A response to the opioid overdose epidemic: naloxone nasal spray</title><author>Wermeling, Daniel P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wermeling, Daniel P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drug delivery and translational research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wermeling, Daniel P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A response to the opioid overdose epidemic: naloxone nasal spray</atitle><jtitle>Drug delivery and translational research</jtitle><stitle>Drug Deliv. and Transl. Res</stitle><addtitle>Drug Deliv Transl Res</addtitle><date>2013-02-01</date><risdate>2013</risdate><volume>3</volume><issue>1</issue><spage>63</spage><epage>74</epage><pages>63-74</pages><issn>2190-393X</issn><eissn>2190-3948</eissn><abstract>Opioid overdose morbidity and mortality is recognized to have epidemic proportions. Medical and public health agencies are adopting opioid harm reduction strategies to reduce the morbidity and mortality associated with overdose. One strategy developed by emergency medical services and public health agencies is to deliver the opioid antidote naloxone injection intranasally to reverse the effects of opioids. Paramedics have used this route to quickly administer naloxone in a needle-free system and avoiding needlestick injuries and contracting a blood-born pathogen disease such as hepatitis or human immunodeficiency virus. Public health officials advocate broader lay person access since civilians are likely witnesses or first responders to an opioid overdose in a time-acute setting. The barrier to greater use of naloxone is that a suitable and optimized needle-free drug delivery system is unavailable. The scientific basis for design and study of an intranasal naloxone product is described. Lessons from nasal delivery of opioid analgesics are applied to the consideration of naloxone nasal spray.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23734342</pmid><doi>10.1007/s13346-012-0092-0</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2190-393X
ispartof Drug delivery and translational research, 2013-02, Vol.3 (1), p.63-74
issn 2190-393X
2190-3948
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3668569
source Springer Nature
subjects Biomedical and Life Sciences
Biomedicine
Pharmaceutical Sciences/Technology
Review Article
title A response to the opioid overdose epidemic: naloxone nasal spray
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20response%20to%20the%20opioid%20overdose%20epidemic:%20naloxone%20nasal%20spray&rft.jtitle=Drug%20delivery%20and%20translational%20research&rft.au=Wermeling,%20Daniel%20P.&rft.date=2013-02-01&rft.volume=3&rft.issue=1&rft.spage=63&rft.epage=74&rft.pages=63-74&rft.issn=2190-393X&rft.eissn=2190-3948&rft_id=info:doi/10.1007/s13346-012-0092-0&rft_dat=%3Cproquest_pubme%3E1665117285%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-518b89f6e57435268185bfd0fd9bb91b7bec2e93addc59709271ead2145a356a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1665117285&rft_id=info:pmid/23734342&rfr_iscdi=true